 |
|
Association of the triglyceride-glucose index with cardiovascular outcomes across cardiovascular-kidney-metabolic syndrome stages
Byung Sik Kim, Hyun-Jin Kim, Shinje Moon, Hasung Kim, Jungkuk Lee, Jeong-Hun Shin
Korean J Intern Med. 2025;40(6):961-974. Published online 2025 Oct 31 DOI: https://doi.org/10.3904/kjim.2025.082
|
|
Citations to this article as recorded by
 Sex-Specific Differences in Cardiovascular-Kidney-Metabolic Syndrome and Clinical Outcomes: A Nationwide Cohort Study
Byung Sik Kim, Hyun-Jin Kim, Hasung Kim, Jungkuk Lee, Jeong-Hun Shin
CardioMetabolic Syndrome Journal.2026; 6(1): 108. CrossRef TyG Index and Frailty as Composite Biomarkers of Cardiometabolic Risk and Mortality Across CKM Stages 0–3
Yaocheng Luo, Peng Zeng, Shuoya Huang, Zhenzhen Peng, Jian Zheng, Zumin Shi, Manoj Sharma, Yong Zhao
Metabolites.2026; 16(6): 426. CrossRef Triglyceride–glucose index and hyperhomocysteinemia within a cardiovascular–kidney–metabolic biomarker network: insights from interpretable machine learning and epidemiological modeling
Hongzhou Liu, Ru Wang, Huadan Zhu, Chuan Song, Li Shi, Manka Zhang, Song Dong, Shuangtong Yan
Frontiers in Nutrition.2026;[Epub] CrossRef Obesity and Cardiovascular Diseases: CVIA State-of-the-Art Review
Naiqi Liu, Yilin Pan, Fukang Liu, Junhao Mei, Xu Zhang, Runzhi Zhang, Shuang Zhang, Fang Luo, Yejun Wu, Yiwen Gong, Yanqin Chen, Qingyun Wu, Shusen Jiang, Shiying Li, Tianhang Yu, Zhenwei Wang, Saiyang Xie, Jiang Yu, Qi Wu, Zhen Wang, Qiang Su, Xingli Xu,
Cardiovascular Innovations and Applications.2026;[Epub] CrossRef
|